Veracyte, Inc. (VCYT) Stock Overview
NASDAQ · Healthcare · Diagnostics & Research
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Veracyte, Inc.
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder…
Source: Yahoo Finance
Sector & Industry
Veracyte, Inc. operates in the Healthcare sector, within the Diagnostics & Research industry group. It is listed on the NASDAQ exchange.
Veracyte, Inc. at a Glance
| Company | Veracyte, Inc. |
| Ticker | VCYT |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $42.53 |
| Market cap | $3.42B |
| P/E ratio (trailing) | 30.38 |
| EPS (trailing) | $1.40 |
| 52-week high | $60.91 |
| 52-week low | $29.45 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 1.93 |
| Return on equity (ROE) | 8.77% |
| Debt-to-equity | 2.89% |
| Average volume | 1.33M |
| Shares outstanding | 80.39M |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Employees | 755 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Frequently Asked Questions
- What is Veracyte, Inc.'s current P/E ratio?
- Veracyte, Inc. (VCYT) has a trailing P/E ratio of 30.38 as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Veracyte, Inc.'s market capitalisation?
- Veracyte, Inc.'s market cap is $3.42B based on our latest snapshot. See how it ranks by market cap →
- What is VCYT's 52-week range?
- Over the past 52 weeks, VCYT has traded between $29.45 and $60.91. What does the 52-week range mean? →
- How volatile is Veracyte, Inc. compared to the market?
- Veracyte, Inc. has a beta of 1.93, meaning it has historically moved more than the broader market. What does beta measure? →
- Does Veracyte, Inc. pay a dividend?
- Veracyte, Inc. does not currently pay a dividend according to our latest data.
- What exchange is VCYT listed on?
- VCYT is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Veracyte, Inc. in?
- Veracyte, Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
For compound interest, percentage change and other investing maths, try our free online calculators.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →